Theriva Biologics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
07 Jun 23 | BuyUS$9,703 | Steven Shallcross | Individual | 14,000 | US$0.69 | |
06 Jun 23 | BuyUS$16,453 | Steven Shallcross | Individual | 26,000 | US$0.63 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 145 | 0.000851% |
Individual Insiders | 331,299 | 1.94% |
Institutions | 1,052,028 | 6.17% |
General Public | 15,659,293 | 91.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
366,580 | US$184.4k | -28.5% | no data | |||
250,000 | US$125.7k | 0% | no data | |||
190,060 | US$95.6k | -0.06% | no data | |||
141,168 | US$71.0k | 0% | no data | |||
80,645 | US$40.6k | 0% | no data | |||
59,210 | US$29.8k | 9.22% | no data | |||
57,953 | US$29.1k | 0% | no data | |||
48,691 | US$24.5k | 0% | no data | |||
47,559 | US$23.9k | 174% | no data | |||
39,121 | US$19.7k | 0% | no data | |||
28,528 | US$14.3k | 0% | no data | |||
26,599 | US$13.4k | 0% | no data | |||
13,566 | US$6.8k | 0% | no data | |||
11,000 | US$5.5k | 0% | no data | |||
10,712 | US$5.4k | 0% | no data | |||
10,153 | US$5.1k | 0% | no data | |||
654 | US$329.1 | 0% | no data | |||
515 | US$258.8 | 5,050% | no data | |||
296 | US$149.1 | -22.5% | no data | |||
145 | US$72.9 | 0% | no data | |||
131 | US$66.0 | 5.65% | no data | |||
100 | US$50.6 | 0% | no data | |||
42 | US$21.4 | -50% | no data | |||
14 | US$6.9 | 0% | no data | |||
9 | US$4.3 | -91% | no data |